Vaccination Recommendations for the Hematology and Oncology and Post–Stem Cell Transplant Populations
Vivian Tsang, PharmD, BCOP
From Cedars-Sinai Medical Center, Los Angeles, California
The author has no conflicts of interest to disclose.
Correspondence to: Vivian Tsang, PharmD, BCOP, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Los Angeles, CA 90048. E-mail: email@example.com
J Adv Pract Oncol 2012;3:71–83 |
DOI: 10.6004/jadpro.2012.3.2.2 |
© 2012 Harborside Press®
Vaccination is a simple yet important process used to prevent many infections in the general population. For patients with suppressed immune systems, especially those who are undergoing chemotherapy or who have undergone stem cell transplant, repeat vaccination or boosters may be crucial in prolonging and/or extending immunity. The purpose of this review is to examine the need for each vaccine in two separate oncology populations: patients receiving concurrent chemotherapy and post–stem cell transplant patients. In addition, the importance of avoiding live vaccines and criteria for reconsideration at a future time will also be discussed.
For access to the full length article, please sign in